Clinical Trial Update: HUmira in Psoriatic Arthritis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating adalimumab (Humira) for psoriatic arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: Glostrup University Hospital, Copenhagen | Conditions: Psoriatic Arthritis | Phase 4 | Status: COMPLETED